Clinical potential and challenges of spatially profiling tumor-infiltrating lymphocytes in early-stage breast cancer

Key Points

• This research aims to evaluate the clinical potential of spatially profiling tumor-infiltrating lymphocytes to predict outcomes in early-stage breast cancer.
• Utilized digitally automated spatial profiling with multispectral immunofluorescence.
• Focused on immune-tumor cell interactions.
• Identified challenges for clinical adoption through prospective validation.
• Spatial profiling shows promise as a biomarker for early-stage breast cancer.
• Harmonization with existing biomarkers is necessary for clinical use.
• Challenges in validation may impact adoption timelines.